Capsules containing high doses of krill phospholipids

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10960016
APP PUB NO 20170182073A1
SERIAL NO

15118343

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Oral capsules have been dismissed as a dosage form for delivery high dosages of krill phospholipids, but by purifying these to high levels it is indeed possible to use this dosage form to deliver, for example, 700 mg or more phospholipids per capsule.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AKER BIOMARINE HUMAN INGREDIENTS ASP O BOX 496 LYSAKER NO - 1327

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Evjen, Tove Jule Oslo, NO 2 0
Hupfeld, Stefan Oslo, NO 4 3
Myhren, Finn Oslo, NO 39 156
Thøgersen, Håvard Oslo, NO 5 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 30, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 30, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00